These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 7041325

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of the in vitro fibrinolytic activities of low and high molecular weight single-chain urokinase-type plasminogen activator.
    de Munk GA, Groeneveld E, Rijken DC.
    Thromb Haemost; 1993 Sep 01; 70(3):481-5. PubMed ID: 8259553
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O, Rijken DC, Collen D.
    Thromb Haemost; 1981 Jun 30; 45(3):225-9. PubMed ID: 7025339
    [Abstract] [Full Text] [Related]

  • 4. The pH dependence of the binding of pro-urokinase to fibrin/celite.
    Pannell R, Angles-Cano E, Gurewich V.
    Thromb Haemost; 1990 Dec 28; 64(4):556-8. PubMed ID: 2128139
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Urokinase quality: analysis of different preparations.
    Rogatti W, Yokoigawa K, Kobayashi T.
    Thromb Haemost; 1985 Apr 22; 53(2):245-8. PubMed ID: 4024035
    [Abstract] [Full Text] [Related]

  • 7. Comparison of thrombolytic, fibrinolytic, and fibrinogenolytic properties of tissue plasminogen activator, streptokinase, single-chain urokinase, high molecular weight and low molecular weight urokinase in human plasma in vitro.
    Samama M, Nguyen G, Desnoyers P, Lourenco DM, Fretault J, Horellou MH, Conard J, Szwarcer E, Verdy E, Vahanian A.
    Fundam Clin Pharmacol; 1988 Apr 22; 2(6):509-23. PubMed ID: 3149257
    [Abstract] [Full Text] [Related]

  • 8. Fibrin clot lysis by thrombolytic agents is impaired in newborns due to a low plasminogen concentration.
    Andrew M, Brooker L, Leaker M, Paes B, Weitz J.
    Thromb Haemost; 1992 Sep 07; 68(3):325-30. PubMed ID: 1440499
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins.
    Toki N, Sumi H, Sasaki K, Boreisha I, Robbins KC.
    J Clin Invest; 1985 Apr 07; 75(4):1212-22. PubMed ID: 3921568
    [Abstract] [Full Text] [Related]

  • 11. Biological and thrombolytic properties of proenzyme and active forms of human urokinase--I. Fibrinolytic and fibrinogenolytic properties in human plasma in vitro of urokinases obtained from human urine or by recombinant DNA technology.
    Zamarron C, Lijnen HR, Van Hoef B, Collen D.
    Thromb Haemost; 1984 Aug 31; 52(1):19-23. PubMed ID: 6495259
    [Abstract] [Full Text] [Related]

  • 12. Studies on metabolism of urokinase and mechanism of thrombolysis by urokinase.
    Ueno T, Kobayashi N, Maekawa T.
    Thromb Haemost; 1979 Oct 31; 42(3):885-94. PubMed ID: 505403
    [Abstract] [Full Text] [Related]

  • 13. [The location of components of fibrinolytic system in laryngeal cancer].
    Sierko E, Tokajuk P, Zimnoch L, Wojtukiewicz MZ.
    Pol Merkur Lekarski; 2003 Jul 31; 15(85):81-5. PubMed ID: 14593967
    [Abstract] [Full Text] [Related]

  • 14. The plasmin heavy chain-urokinase conjugate: a specific thrombolytic agent.
    Nakayama Y, Shinohara M, Tani T, Kawaguchi T, Furuta T, Izawa T, Kaise H, Miyazaki W, Nakano Y.
    Thromb Haemost; 1986 Dec 15; 56(3):364-70. PubMed ID: 2951892
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A comparative study of high molecular weight urokinase and low molecular weight urokinase.
    Nobuhara M, Sakamaki M, Ohnishi H, Suzuki Y.
    J Biochem; 1981 Jul 15; 90(1):225-32. PubMed ID: 7026550
    [Abstract] [Full Text] [Related]

  • 17. In vitro studies on the fibrinolytic, thrombolytic and fibrinogenolytic properties of a tissue plasminogen activator from guinea pig keratocytes.
    Electricwala A, Ling RJ, Sutton PM, Griffiths B, Riley PA, Atkinson T.
    Thromb Haemost; 1985 Apr 22; 53(2):200-3. PubMed ID: 4040659
    [Abstract] [Full Text] [Related]

  • 18. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
    Veremeenko KN, Kizim AI.
    Vopr Med Khim; 1984 Apr 22; 30(5):13-22. PubMed ID: 6084892
    [Abstract] [Full Text] [Related]

  • 19. Immunochemical studies of high and low molecular forms of urokinase.
    Sumi H, Toki N, Maehara S, Kosugi T, Akazawa K, Matsuo O, Mihara H.
    Acta Haematol; 1982 Apr 22; 67(4):263-7. PubMed ID: 6810625
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.